TRU-015, a small modular immunopharmaceutical (SMIP™) drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis

Detalles Bibliográficos
Autores principales: Burge, DJ, Shu, C, Martin, RW, Littlejohn, TW, Wallace, DJ, Taborn, J, Palmer, WR, Kivitz, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061958/
http://dx.doi.org/10.1186/ar2258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061958/
http://dx.doi.org/10.1186/ar2258

Ejemplares similares